ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 127755 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 127755; 2) Community: the network communities that were significantly associated with the response to NSC 127755; 3) Molecule: the relationships between components within communities and NSC 127755; 4) MDR: the compounds that were significantly associated with the NSC 127755.

NSC Compound Enrichment Correlation
NSC 701383 Null 0.00140570135773563 0.41501495
NSC 716951 Null 0.00140570135773563 0.51460218
NSC 721049 7Z-Plakortide H 0.00140570135773563 0.15680839
NSC 722867 Null 0.00140570135773563 0.27374636
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00140570135773563 0.20060326
NSC 740 Methotrexate 0.00140570135773563 0.6787248
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.00172065213317245 0.55475735
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00172065213317245 0.60681356
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.00172065213317245 0.53471961
NSC 63878 Cytarabine Hydrochloride AZ 0.00172065213317245 0.47485213
Total:108  Current:8    [First] [Prev] [Next] [Last]